TrialOncoimmunology2020

Anti-cancer immunotherapy using cancer-derived multiple epitope-peptides cocktail vaccination clinical studies in patients with refractory/persistent disease of uterine cervical cancer and ovarian cancer [phase 2].

Satoshi Takeuchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.